Johnson & Johnson's (J&J) decision to fight the more than 100,000 lawsuits against it in court is a strategy to deter future claims it thinks are "without merit", according to lawyers battling the pharma giant. The company has been fighting for years over its blockbuster drug Vioxx, which was withdrawn from sale by US regulators after causing heart attacks and strokes.
Johnson & Johnson's (J&J) decision to fight the more than 100,000 lawsuits against it in court is a strategy to deter future claims it thinks are "without merit", according to lawyers battling the pharma giant. J&J faces paying billions in compensation, but legal experts said the company has won its fair share of cases too and could emulate Merck by eventually moving to less costly settlements.